Abstract
Purpose: Immune checkpoint blockade (ICB) therapy shows little or no clinical benefit in most colorectal cancer (CRC) patients, due to the immunosuppr......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
